Observational data suggest apixaban leads to fewer thromboembolic events but higher bleeding risk, highlighting the need for ...
The use of the osteoporosis drug denosumab (Prolia) to prevent fractures associated with advanced chronic kidney disease (CKD) in patients on kidney dialysis significantly increases the risk for ...
A new UC Davis Health study reveals that transportation challenges create major barriers for patients with end-stage kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results